The effect of selective neutrophil elastase inhibitor on pancreatic islet yields and functions in rat with hypercytokinemia

Annals of Transplantation

Volumn 16, Issue 4, 2011, Pages 99-106

  Ono, Shinichiro ^a   Kuroki, Tamotsu ^a   Adachi, Tomohiko ^a   Kosaka, Taichiro ^a   Okamoto, Tatsuya ^a   Tanaka, Takayuki ^a   Tajima, Yoshitsugu ^a   Kanematsu, Takashi ^a   Eguchi, Susumu ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Brain death; Hypercytokinemia; Islet transplantation; Sivelestat sodium

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SIVELESTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEATH; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE STORM; DRUG ACTIVITY; DRUG EFFICACY; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PROTEIN BLOOD LEVEL; RAT;

EID: 84862928253     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/aot.882225     Document Type: Article

References (44)

1. Bretzel RG, Alejandro R, Hering BJ et al: Clinical islet transplantation: guideline for islet quality control. Transplantation Proc, 1994; 26: 388-92
2. Osama GA, Chamsuddin, A, Fraga D et al: Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation. Transplantation, 2004; 77: 309-11
3. Markmann JF, Deng S, Huang X et al: Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg, 2003; 237: 741-49
4. Shapiro AM, Lakey JR, Ryan EA et al: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med, 2000; 343: 230-38
5. Hering BJ, Browatzki CC, Schultz AO et al: Islet transplant registry report on adult and fetal islet allografts. Transplant Proc, 1994; 26: 565-68
6. Tsujimura T, Kuroda Y, Kin T et al: Human islet transplantation from pancreas with prolonged cold ischemia using additional preservation by the twolayer (UW solution/perfluorochemical) cold-storage method. Transplantation, 2002; 74: 1687-91
7. Layey JR, Burridge PW, Shapiro AM: Technical aspects of islet preparation and transplantation. Transplant Int, 2003; 16: 613-32
8. Ryan EA, Lakey JR, Rajotte RV et al: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes, 2001; 50: 710-19
9. Kim SC, Han DJ, Kang CH et al: Analysis on donor and isolation-related factors of successful isolation of human islet of Langerhans from human cadaveric donors. Transplant Proc, 2005; 37: 3402-3
10. Nano R, Clissi B, Meizi R et al: Islet isolation for allotransplantation: variables associated with successful islet yield and graft function. Diabetologia, 2005; 48: 906-12
11. Goto M, Johansson U, Eich TM et al: Key factors for human islet isolation and clinical transplantation. Transplant Proc, 2005; 37: 1315-16
12. O'Gorman D, Kin T, Murdoch T et al: The standardization of pancreatic donors for islet isolations. Transplantation, 2005; 80: 801-6
13. Jung HS, Choi SH, Kim SJ et al: A better yield of islet cell mass from living pancreatic donors compared cadaveric donors. Clin Transplant, 2007; 21: 738-43
14. Contreas JL, Eckstein C, Smyth CA et al: Brain death siginificantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes, 2003; 52: 2935-42
15. Takada M, Nadeau KC, Hancock WW et al: Effects of explosive brain death on cytokine activation on peripheral organs in the rat. Transplantation, 1998; 65: 1533-42
16. Pratschke J, Wilhelm MJ, Kusaka M et al: A model of gradual on set brain death for transplant-associated studies in rats. Transplantation, 2000; 69: 427-30
17. Delaney CA, Pavlovic D, Hoorens A et al: Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology, 1997; 138: 2610-14
18. Montolio M, Biarrne's M, Te'llez N et al: Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation. J Endocrinol, 2007; 192: 169-77
19. Welsh N, Eizirik DL, Bendtzen K, Sandler S: Interleukin-1b-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology, 1991; 129: 3167-73
20. Anne H, Geert S, Dejan P, Daniel P: Distiction between Interleukin-1-induced necrosis and apoptosis of islet cells. Diabetes, 2001; 50: 551-57
21. Kawabata K, Suzuki M, Sugitani M et al: Ono-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun, 1991; 177: 814-20
22. Tamakuma S, Ogawa M, Aikawa N et al: Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther, 2004; 17: 271-79
23. Hayakawa M, Katabami K, Wada T et al: Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both ARDS and DIC patients. Shock, 2010; 33: 14-18
24. Endo S, Sato N, Yaeguchi Y et al: Sivelestat sodium hydrate improves septic acute lung injury by reducing alveolar dysfunction. Res Commun Mol Pathol Pharmacol, 2006; 119: 53-65
25. Okamoto T, Kuroki T, Adachi T et al: Effect of Zinc on early graft failure following intraportal islet transplantation in rat recipients. Ann Transplant, 2011; 16: 114-20
26. Barklin A: Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand, 2009; 53: 425-35
27. Murugan R, Venkataraman R, Wahed AS et al: Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med, 2008; 36: 1810-16
28. Birks EJ, Owen VJ, Burton PB et al: Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation, 2000; 102: 326-31
29. Sparre T, Larsen MR, Heding PE et al: Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions. Mol Cell Proteomics, 2005; 4: 441-57
30. Nielsen K, Kruhoffer M, Orntoft T et al: Gene expression profiles during b cell maturation and after IL-1b exposure reveal important roles of Pdx-1 and Nkx6.1 for IL-1b sensitivity. Diabetelogia, 2004; 48: 2185-99
31. Kutlz B, Cardozo AK, Darville MI et al: Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes, 2003; 52: 2701-19
32. Yamaki E, Ogata K, Hinohara H et al: Effects of neutrophil elastase inhibitor on postoperative cytokine levels in patients after esophagectomy. Masui, 2005; 54: 884-88
33. Hagiwara S, Iwasaka H, Hidaka S et al: Neutrophil elastase inhibitor (sivelestat) reduces the levels of inflammatory mediators by inhibiting NF-kB. Inflamm Res, 2009; 58: 198-203
34. Matsuzaki K, Hiramatsu Y, Homma S et al: Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg, 2005; 80: 611-17
35. Misumi T, Tanaka T, Mikawa K et al: Effects of sivelestat, a new elastase inhibitor, on IL-8 and MCP-1 production from stimulated human alveolar epithelial type cells. J Aneth, 2006; 20: 159-65
36. Nakashima M, Kanemaru M: A phase 1 clinical study of neutrophil elastase inhibitor; ONO-5046-Na in healthy volunteers (in Japanese with English abstract). Rinsho Iyaku (J Clin Ther Med), 1998; 14: 195-218
37. Ravinovitch A, Suarez-Pinzon WL, Strynadka K et al: Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endcrinol Metab, 1996; 81: 3197-202
38. Sandlers S, Bendtzen K, Borg LA et al: Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1b indicate a perturbation in the mitochondrial function. Endocrinology, 1989; 124: 1492-501
39. Delaney CA, Pavlovic D, Hoorens A et al: Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocriology, 1997; 138: 2610-14
40. Welsh N, Margulis B, Borg LA et al: Difference in the expression of heart-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathgenesis of insulin-dependent diabetes mellitus. Mol Med, 1995; 1: 806-20
41. Heimberg H, Heremans Y, Jobin C et al: Inhibition of cytokine induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes, 2001; 50: 2219-24
42. Eldor R, Yeffet A, Baum K et al: Conditional and specitic NF-kappaB blockade protects pancreatic beta cells from diabeteogenic agents. Proc Nati Acad Sci USA, 2006; 103: 5072-77
43. Noguchi H: Production of pancreatic beta-cells from stem cells. Curr Diabetes Rev, 2010; 6: 184-90
44. Wang X, Ye K: Three-dimensional differentiation of embryonic stem cells into islet-like insulin-producing clusters. Tissue Enginnering, 2009; 15: 1941-52